Since the HR status can change over time due to evolutionary tumor and treatment selection and cell lines are exposed to genetic drift, we hypothesized that functional HR status better reflects real-time HR status than BRCA1/2 mutation status. The gene discussed is BRCA1; the disease is neoplasm.